SRTA Strangle Strategy
SRTA (Strata Critical Medical, Inc.), in the Industrials sector, (Airlines, Airports & Air Services industry), listed on NASDAQ.
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
SRTA (Strata Critical Medical, Inc.) trades in the Industrials sector, specifically Airlines, Airports & Air Services, with a market capitalization of approximately $469.8M, a trailing P/E of 9.86, a beta of 2.15 versus the broader market, a 52-week range of 3.31-6.02, average daily share volume of 817K, a public-listing history dating back to 2019, approximately 310 full-time employees. These structural characteristics shape how SRTA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.15 indicates SRTA has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 9.86 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a strangle on SRTA?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current SRTA snapshot
As of May 15, 2026, spot at $5.25, ATM IV 69.50%, IV rank 36.06%, expected move 19.93%. The strangle on SRTA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on SRTA specifically: SRTA IV at 69.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 19.93% (roughly $1.05 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SRTA expiries trade a higher absolute premium for lower per-day decay. Position sizing on SRTA should anchor to the underlying notional of $5.25 per share and to the trader's directional view on SRTA stock.
SRTA strangle setup
The SRTA strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SRTA near $5.25, the first option leg uses a $5.51 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SRTA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SRTA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.51 | N/A |
| Buy 1 | Put | $4.99 | N/A |
SRTA strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
SRTA strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on SRTA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on SRTA
Strangles on SRTA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SRTA chain.
SRTA thesis for this strangle
The market-implied 1-standard-deviation range for SRTA extends from approximately $4.20 on the downside to $6.30 on the upside. A SRTA long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current SRTA IV rank near 36.06% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on SRTA should anchor more to the directional view and the expected-move geometry. As a Industrials name, SRTA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SRTA-specific events.
SRTA strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SRTA positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SRTA alongside the broader basket even when SRTA-specific fundamentals are unchanged. Always rebuild the position from current SRTA chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on SRTA?
- A strangle on SRTA is the strangle strategy applied to SRTA (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With SRTA stock trading near $5.25, the strikes shown on this page are snapped to the nearest listed SRTA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SRTA strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the SRTA strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 69.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SRTA strangle?
- The breakeven for the SRTA strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SRTA market-implied 1-standard-deviation expected move is approximately 19.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on SRTA?
- Strangles on SRTA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SRTA chain.
- How does current SRTA implied volatility affect this strangle?
- SRTA ATM IV is at 69.50% with IV rank near 36.06%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.